HUMACYTE INC. - COMMO

Humacyte Announces Pricing of $30.0 Million Registered Direct Offering

04 أكتوبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Humacyte to Host Virtual KOL Event to Discuss Case Studies on the Use of Acellular Tissue Engineered Vessel (ATEV™) in Vascular Trauma Treatment on September 30, 2024

26 سبتمبر 2024 17:26:25 بحسب Nasdaq GlobeNewswire

Humacyte Announces Allowance of U.S. Patent Covering BioVascular Pancreas (BVP™)

19 سبتمبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Humacyte to Participate at Upcoming Investor Conferences in September

03 سبتمبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Humacyte Presents Positive Long-Term Results of ATEV™ in Treatment of Vascular Trauma in Military Setting from Ukraine Humanitarian Program

27 أغسطس 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Humacyte Second Quarter 2024 Financial Results and Business Update

13 أغسطس 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Humacyte to Present Second Quarter Financial Results and Provide Corporate Update on August 13, 2024

12 أغسطس 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Humacyte Announces FDA Communication of Additional Time Required to Complete Review of acellular tissue engineered vessel (ATEV™) BLA for the Treatment of Vascular Trauma

09 أغسطس 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Humacyte Acellular Tissue Engineered Vessel (ATEV™) Meets Primary Endpoints in V007 Phase 3 Clinical Trial in Arteriovenous Access for Hemodialysis

31 يوليو 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Humacyte Board of Directors Strengthened with Addition of John P. Bamforth and Keith Anthony Jones

16 يوليو 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Humacyte Acellular Tissue Engineered Vessel (ATEV™) Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for Patients with Advanced Peripheral Artery Disease (PAD)

01 يوليو 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Humacyte Presents Positive Preclinical Data For Its BioVascular Pancreas (BVP™) Program

25 يونيو 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Centers for Medicare & Medicaid Services (CMS) Issues ICD-10-PCS Codes for Humacyte’s Human Acellular Vessel™ (HAV™)

17 يونيو 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Humacyte to Present at the Jefferies Global Healthcare Conference

30 مايو 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Humacyte to Participate at Upcoming Investor Conferences in May

13 مايو 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Humacyte First Quarter 2024 Financial Results and Business Update

10 مايو 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 10, 2024

06 مايو 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Humacyte to Host Virtual KOL Event “Hemodialysis Access: A Crossroads of Care,” on March 28, 2024

26 مارس 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Humacyte Fourth Quarter and Year End 2023 Financial Results and Business Update

22 مارس 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Humacyte to Present 2023 Fourth Quarter and Year-End Financial Results and Provide Corporate Update on March 22, 2024

18 مارس 2024 08:00:00 بحسب Nasdaq GlobeNewswire